Skip to main content

Advertisement

SpringerLink
Log in

Fanconi Anemia Gene Variants in Patients with Gonadal Dysfunction

  • Review
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Fanconi anemia (FA) is a multisystem disease, characterized by the triad of physical abnormalities, bone marrow failure, and increased risk for malignancy. In the past few years, data has accumulated regarding fertility issues in FA patients, mostly due to gonadal dysfunction, which is prevalent in FA patients reaching puberty. It seems that attenuated FA phenotype lacking the classical manifestations often is presented with POI or azoospermia. Searching the literature, we summarized data regarding FA patients presenting as suffering from sub/infertility due to gonadal dysfunction, with or without other FA symptoms. We present a summary of the patients having biallelic pathogenic variants in FA genes FANCA, FANCM, BRCA2, and XRCC2 that presented with gonadal dysfunction with or without other phenotypic features of FA. Some were in mosaic, while some are considered hypomorphic, enabling residual protein function. There are also a few descriptions of POI associated with monoallelic pathogenic variants in FANCA, BRCA2, and FANCL. We conclude that the diagnosis of FA in gonadal dysfunction patients is of utmost importance due to its actionability. Follow-up strategies in FA patients are designed to discover early stages of leukemias and solid tumors and thus save lives. The feasibility of next-generation sequencing (NGS) can now ease this diagnostic procedure. An open question is the justification of performing NGS for all isolated azoospermia/POI patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Availability of Data and Material

All resources are specified in the article and in Table 1.

Code Availability

Not applicable.

References

  1. Fiesco-Roa MO, Giri N, McReynolds LJ, Best AF, Alter BP. Genotype-phenotype associations in Fanconi anemia: a literature review. Blood Rev. 2019;37:100589.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Mehta PA, Tolar J, Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G,  Amemiya  A. In: GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. 2002 Feb 14 [updated 2018 Mar 8].

  3. Alter BP. Bone marrow failure: a child is not just a small adult (but an adult can have a childhood disease). Hematology Am Soc Hematol Educ Program. 2005;2005:96–103.

    Article  Google Scholar 

  4. Tan IB, Cutcutache I, Zang ZJ, Iqbal J, Yap SF, Hwang W, et al. Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing. J Clin Oncol. 2011;29:e591–4.

    Article  PubMed  Google Scholar 

  5. Krausz C, Riera-Escamilla A, Chianese C, Moreno-Mendoza D, Ars E, Rajmil O, et al. From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia. Genet Med. 2019;21:189–94.

    Article  CAS  PubMed  Google Scholar 

  6. Tsui V, Crismani W. The Fanconi anemia pathway and fertility. Trends Genet. 2019;35:199–214.

    Article  CAS  PubMed  Google Scholar 

  7. Petryk A, Kanakatti Shankar R, Giri N, Hollenberg AN, Rutter MM, Nathan B, et al. Endocrine disorders in Fanconi anemia: recommendations for screening and treatment. J Clin Endocrinol Metab. 2015;100:803–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Bonfim C, Ribeiro L, Nichele S, Bitencourt M, Loth G, Koliski A, et al. Long-term survival, organ function, and malignancy after hematopoietic stem cell transplantation for fanconi anemia. Biol Blood Marrow Transplant. 2016;22:1257–63.

    Article  PubMed  Google Scholar 

  9. Yang X, Zhang X, Jiao J, Zhang F, Pan Y, Wang Q, et al. Rare variants in FANCA induce premature ovarian insufficiency. Hum Genet. 2019;138:1227–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bogliolo M, Bluteau D, Lespinasse J, Pujol R, Vasquez N, d'Enghien CD, et al. Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia. Genet Med. 2018;20:458–63.

    Article  CAS  PubMed  Google Scholar 

  11. Catucci I, Osorio A, Arver B, Neidhardt G, Bogliolo M, Zanardi F, et al. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility. Genet Med. 2018;20:452–7.

    Article  CAS  PubMed  Google Scholar 

  12. Fouquet B, Pawlikowska P, Caburet S, Guigon C, Mäkinen M, Tanner L, et al. A homozygous FANCM mutation underlies a familial case of non-syndromic primary ovarian insufficiency. Elife. 2017;6:e30490.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kasak L, Punab M, Nagirnaja L, Grigorova M, Minajeva A, Lopes AM, et al. Bi-allelic recessive loss-of-function variants in FANCM cause non-obstructive azoospermia. Am J Hum Genet. 2018;103:200–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Yin H, Ma H, Hussain S, Zhang H, Xie X, Jiang L, et al. A homozygous FANCM frameshift pathogenic variant causes male infertility. Genet Med. 2019;21:62–70.

    Article  PubMed  Google Scholar 

  15. Weinberg-Shukron A, Rachmiel M, Renbaum P, Gulsuner S, Walsh T, Lobel O, et al. Essential role of BRCA2 in ovarian development and function. N Engl J Med. 2018;379:1042–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Miao Y, Wang P, Xie B, Yang M, Li S, Cui Z, et al. BRCA2 deficiency is a potential driver for human primary ovarian insufficiency. Cell Death Dis. 2019;10:474.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Turchetti D, Zuntini R, Tricarico R, Bellacosa A. BRCA2 in ovarian development and function. N Engl J Med. 2019;380:1086–7.

    Article  PubMed  Google Scholar 

  18. Caburet S, Heddar A, Dardillac E, Creux H, Lambert M, Messiaen S, et al. Homozygous hypomorphic BRCA2 variant in primary ovarian insufficiency without cancer or Fanconi anaemia trait. J Med Genet. 2020. https://doi.org/10.1136/jmedgenet-2019-106672.

  19. Qin Y, Zhang F, Chen ZJ. BRCA2 in ovarian development and function. N Engl J Med. 2019;380:1086.

    Article  PubMed  Google Scholar 

  20. Winship AL, Willson C, Hansen KR, Hutt KJ, Hickey M. Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study. BMJ Open. 2019;9:e033810.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Park JY, Virts EL, Jankowska A, Wiek C, Othman M, Chakraborty SC, et al. Complementation of hypersensitivity to DNA interstrand crosslinking agents demonstrates that XRCC2 is a Fanconi anaemia gene. J Med Genet. 2016;53:672–80.

    Article  CAS  PubMed  Google Scholar 

  22. Shamseldin HE, Elfaki M, Alkuraya FS. Exome sequencing reveals a novel Fanconi group defined by XRCC2 mutation. J Med Genet. 2012;49:184–6.

    Article  CAS  PubMed  Google Scholar 

  23. Monies D, Abouelhoda M, Assoum M, Moghrabi N, Rafiullah R, Almontashiri N, et al. Lessons learned from large-scale, first-tier clinical exome sequencing in a highly consanguineous population. Am J Hum Genet. 2019;105:879.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Alhathal N, Maddirevula S, Coskun S, Alali H, Assoum M, Morris T, et al. A genomics approach to male infertility. Genet Med. 2020;22:1967–75.

    Article  CAS  PubMed  Google Scholar 

  25. Yang Y, Guo J, Dai L, Zhu Y, Hu H, Tan L, et al. XRCC2 mutation causes meiotic arrest, azoospermia and infertility. J Med Genet. 2018;55:628–36.

    Article  CAS  PubMed  Google Scholar 

  26. Zhang YX, Li HY, He WB, Tu C, Du J, Li W, et al. XRCC2 mutation causes premature ovarian insufficiency as well as non-obstructive azoospermia in humans. Clin Genet. 2019;95:442–3.

    Article  CAS  PubMed  Google Scholar 

  27. Zlotogora J, Dagan J, Ganen A, Abu-Libdeh M, Ben-Neriah Z, Cohen T. A syndrome including thumb malformations, microcephaly, short stature, and hypogonadism. J Med Genet. 1997;34:813–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Israeli ministry of health: Recommendations for carrier screening. In: https://www.health.gov.il/Subjects/Genetics/prof/Pages/default.aspx.

  29. Yang Y, Guo T, Liu R, Ke H, Xu W, Zhao S, et al. FANCL gene mutations in premature ovarian insufficiency. Hum Mutat. 2020;41:1033–41.

    Article  CAS  PubMed  Google Scholar 

  30. Bieth E, Hamdi SM, Mieusset R. Genetics of the congenital absence of the vas deferens. Hum Genet. 2021;140(1):59–76.

  31. Alvarez-Mora MI, Todeschini AL, Caburet S, Perets LP, Mila M, Younis JS, et al. An exome-wide exploration of cases of primary ovarian insufficiency uncovers novel sequence variants and candidate genes. Clin Genet. 2020;98(3):293–8.

  32. Cocuzza M, Alvarenga C, Pagani R. The epidemiology and etiology of azoospermia. Clinics (Sao Paulo). 2013;68(Suppl 1):15–26.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Mrs. Sarah Cohen for the language editing.

Author information

Authors and Affiliations

  1. Department of Genetics, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel

    Hagit Daum

  2. Department of Genetics, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel

    Joël Zlotogora

Authors
  1. Hagit Daum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joël Zlotogora
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Both authors took part in review design, execution, analysis, manuscript drafting, and critical discussion.

Corresponding author

Correspondence to Hagit Daum.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Daum, H., Zlotogora, J. Fanconi Anemia Gene Variants in Patients with Gonadal Dysfunction. Reprod. Sci. 29, 1408–1413 (2022). https://doi.org/10.1007/s43032-021-00582-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43032-021-00582-7

Keywords

Search

Navigation